Engage Therapeutics
Summit, US · Founded 2016 · Delaware corporation · 2 known investors
Company whose formation and launch the LifeSci team supported.
Founders & leadership
Engage Therapeutics was founded in 2016 by Gregory Mayes.
GM
Gregory MayesFounder
JI
Jouko IsojarviNamed on SEC filing
SD
Stephen D. CollinsNamed on SEC filing
WL
Warren LammertNamed on SEC filing
OD
Orrin DevinskyNamed on SEC filing
Board
GB

HL
Heath LukatchBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$30.6M disclosed across 2 rounds · 2017–2019
▶$7MraisedOct 2019 · 18 investors · PharmaceuticalsRule 506(b)
▶$7MraisedOct 2019 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Heath LukatchDirector
- Gerry BrunkDirector
- Jouko IsojarviExecutive Officer
- Orrin DevinskyDirector
- Warren LammertDirector
- Gregory MayesExecutive Officer, Director, Promoter
- Stephen CollinsDirector
- Mark TheeuwesExecutive Officer
- Offering amount
- $12M
- Amount sold
- $7M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$23.6MraisedOct 2017 · 16 investors · PharmaceuticalsRule 506(b)
▶$23.6MraisedOct 2017 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jouko IsojarviExecutive Officer
- Stephen D. CollinsDirector
- Gregory MayesExecutive Officer, Director, Promoter
- Gerry BrunkDirector
- Heath LukatchDirector
- Warren LammertDirector
- Orrin DevinskyDirector
- Offering amount
- $23.6M
- Amount sold
- $23.6M
- Sales commissions
- $600K
- Placement agents
- LifeSci Capital LLC
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Engage Therapeutics do?
- Company whose formation and launch the LifeSci team supported.
- Who founded Engage Therapeutics?
- Engage Therapeutics was founded by Gregory Mayes in 2016.
- Who are Engage Therapeutics's investors?
- Engage Therapeutics's investors include LifeSci Venture Partners, Lumira Ventures.
- How much funding has Engage Therapeutics raised?
- Engage Therapeutics has disclosed $30.6M raised across 2 rounds.
- Where is Engage Therapeutics headquartered?
- Engage Therapeutics is headquartered in Summit, US.